Searchable abstracts of presentations at key conferences in endocrinology

ea0014oc8.6 | Neuroendocrinology clinical | ECE2007

Improved glucocorticoid replacement therapy by a novel oral hydrocortisone modified-release tablet

Skrtic Stanko , Lennernäs Hans , Nilsson Anna , Bergthorsdottir Ragnhildur , Hedner Thomas , Johannsson Gudmundur

Background: Mortality rate in patients with primary and secondary adrenal insufficiency is increased. A contributing factor could be the dose and the pattern of glucocorticoid replacement therapy. Hydrocortisone administered twice or thrice daily produces high serum peaks and low trough values in-between. A novel, once daily, hydrocortisone modified release tablet with combined immediate and extended release characteristics was developed.Purpose: The aim...

ea0014oc12.5 | Diabetes | ECE2007

The influence of concomitant diabetes mellitus on mortality in Addison’s disease

Bergthorsdottir Ragnhildur , Leonsson-Zachrisson Maria , Odén Anders , Johannsson Gudmundur

Background: The prevalence of type 1 diabetes mellitus (DM) among patients with primary adrenal insufficiency (Addison’s disease) is 3-4 times higher than the expected prevalence in the population. The mortality rate due to DM is more than 3-fold the mortality rate in the background population. The impact of DM on mortality rate in patients with Addison’s disease is not known.Objectives: To study the frequency of DM and its impact on mortality ...

ea0014p63 | (1) | ECE2007

Does screening of primary hyperaldosteronism only lead to diagnosis of more adrenal hyperplasia?

Sigurjonsdottir Helga , Gronowitz Mikael , Anderson Ove , Eggertsen Robert , Herlitz Hans , Johannsson Gudmundur

Background: The prevalence of primary hyperaldosteronism (PA) has recently been reported as high as 7.5% in patients with hypertension from unselected populations (USP) and up to 22% in selected populations (SP). Whether increased screening and diagnosis of PA will lead to more findings of curable PA (aldosterone producing adenoma, APA) is unclear.Methods: Three-hundred fifty-three consecutive patients with hypertension, age 20 to 88 years were included ...

ea0056gp2 | Acromegaly | ECE2018

Retinal vessel abnormalities in acromegaly

Fuchtbauer Laila , Olsson Daniel S , Norrman Lise-Lott , Bengtsson Bengt-AEke , Hellstrom Ann , Johannsson Gudmundur

Growth hormone (GH) and insulin like growth factor 1 (IGF-I) modulate and stimulate angiogenesis and endothelial function. Excess of GH, as in acromegaly, is associated with cardiovascular morbidity and mortality, which is reversible after normalization of IGF-I and GH. Diabetes mellitus (DM) is a common comorbidity in acromegaly, but the prevalence of diabetes retinopathy in patients with acromegaly is unknown. Also, the roles of GH and IGF-I in diabetes retinopathy are not f...

ea0056p67 | Adrenal cortex (to include Cushing's) | ECE2018

Adrenal venous sampling in patients with ACTH-independent Cushing’s syndrome

Papakokkinou Eleni , Jakobsson Hugo , Sakinis Augustinas , Muth Andreas , Wangberg Bo , Ehn Olof , Johannsson Gudmundur , Ragnarsson Oskar

Background: ACTH-independent Cushing syndrome (CS) accounts for 15–20% of endogenous CS. Approximately 10% of these patients have bilateral adrenal lesions where the differential diagnoses are primary bilateral adrenal macronodular hyperplasia (PBMAH), primary pigmented nodular adrenal disease (PPNAD), bilateral cortisol producing adenomas or a unilateral cortisol producing adenoma with a contralateral nonfunctioning adenoma. Also, the prevalence of subclinical CS is high...

ea0056p908 | Endocrine Nursing | ECE2018

Patient perspectives on sexuality in hypopituitarism

Bjorkman Ida , Persson Jenny Tiberg , Ung Eva Jakobsson , Olofsson Ann-Charlotte , Johannsson Gudmundur , Dellenborg Lisen

Aim: The aim of the study was to explore patient perspectives on sexuality in hypopituitarism.Background: Hypopituitarism usually leads to a complete loss of sex hormones and the condition has a negative impact on sexuality. Previous research has mainly focused on erectile functioning in men and fertility issues in women but little is known about their sexual wellbeing and experiences of hypopituitarism in relation to sexuality.Des...

ea0073aep39 | Adrenal and Cardiovascular Endocrinology | ECE2021

Increasing incidence of primary aldosteronism – yet an underdiagnosed disorder

Gkaniatsa Eleftheria , Ekerstad Eva , Gavric Emanuela , Trimpou Penelope , Olsson Daniel S. , Johannsson Gudmundur , Ragnarsson Oskar

ContextPrimary aldosteronism (PA) is the most common cause of secondary hypertension. Yet, the incidence of PA in the population has not been studied.ObjectiveTo estimate the incidence of PA in western Sweden.Design and methodsPatients who had received a diagnostic code for PA between 1987 and 2016 were identified in the Swedish National Patient Registry. Assessme...

ea0099oc3.5 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Hip fractures in patients with primary aldosteronism – A Swedish nationwide study

Gkaniatsa Eleftheria , Zverkova Sandstrom Tatiana , Rosengren Annika , Trimpou Penelope , Muth Andreas , Johannsson Gudmundur , Ragnarsson Oskar

Objectives: Clinical studies indicate that primary aldosteronism (PA) is associated with dysregulated bone homeostasis. The aim of this study was to evaluate the incidence of hip fractures in patients with PA.Methods: We studied a nationwide cohort of 2419 patients with PA (1997-2019) and 24 187 age and sex matched controls from the general population. Hip fractures were identified by ICD codes in the Swedish National Patient Register. We estimated hazar...

ea0099p222 | Adrenal and Cardiovascular Endocrinology | ECE2024

Lysophosphatidylcholines and acylcarnitines: Novel markers of physiological glucocorticoid action in adipose tissue

Bennett Kate , Garner Terence , Chantzichristos Dimitrios , Jansson Per-Anders , Stevens Adam , Johannsson Gudmundur

Introduction: Glucocorticoids (GCs) play a crucial role in various physiological processes, with adipose tissue (AT) being an important target organ for their metabolic actions. Besides lipolytic action, the mechanistic regulation of GCs in human AT during physiological exposure is still unclear. We integrated transcriptomic and metabolomic data within the AT to identify mechanistic markers of GC action.Methods: In a randomised, cross-over trial, ten pat...

ea0081rc4.6 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Impact of diabetes on morbidity and mortality in patients with acromegaly

Esposito Daniela , Olsson Daniel S , Franzen Stefan , Gudbjornsdottir Soffia , Miftaraj Mervete , Natman Jonatan , Svensson Ann-Marie , Johannsson Gudmundur

Background: Diabetes is an important risk factor for cardiovascular morbidity and mortality but its impact on outcome in acromegaly is unknown.Methods: This was a nationwide, observational, matched-cohort study. Adult patients with acromegaly due to a pituitary adenoma were identified in the Swedish National Patient Registry between 1987 and 2020 and those with coexistent type 2 diabetes in the National Diabetes Registry and Drug Registry. Overall mortal...